Influenza — SCE Infectious Diseases MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Oral oseltamivir with specialist duration and resistance review
Immunosuppression and severe ongoing lower-respiratory disease justify prompt antiviral treatment even after the optimal 48-hour window. UKHSA uses oseltamivir first-line and advises specialist input about prolonged treatment and resistance in severe or immunosuppressed patients. Inhaled zanamivir may be inappropriate in severe respiratory disease.
Reference: UKHSA influenza antiviral guidance: https://www.gov.uk/government/publications/influenza-treatment-and-prophylaxis-using-anti-viral-agents/guidance-on-use-of-antiviral-agents-for-the-treatment-and-prophylaxis-of-seasonal-influenza